Screening and Secondary Prevention Rheumatic Heart Disease Study
Screening and Secondary Prevention Rheumatic Heart Disease
National Institute of Cardiovascular Diseases, Pakistan
5,000 participants
Sep 26, 2022
OBSERVATIONAL
Conditions
Summary
After basic clinical screening including history and physical, Point of care ultrasound will be performed to look at Mitral, Aortic and Tricuspid Valves for regurgitation or stenosis. For patients with confirmed Rheumatic heart disease (RHD), treatment and referral depending on stage of disease. Antibiotic prescription could be shifted to community health workers delivering preventive medications via practical clinical algorithms, diagnostic tools, availability of appropriate antibiotics, and supportive supervision. Patients will have repeat imaging at 2 years and 5 years to look at the outcome of delayed progression of valve disease.
Eligibility
Inclusion Criteria1
- Rural communities in Sindh
Exclusion Criteria1
- Refused to participate in the study
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05991219